U.S. market Closed. Opens in 1 day 6 minutes

PLSE | Pulse Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
RevenueN/A700.00K1.42MN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue1.21M11.94M1.97M665.00K666.00K665.00K665.00K665.00KN/AN/A
Gross Profit-1.21M-11.24M-550.00K-665.00K-666.00K-665.00K-665.00K-665.00KN/AN/A
Operating Expenses43.57M46.81M62.46M49.97M47.95M37.96M25.81M9.59M4.47M514.29K
Selling, General & Admin15.78M25.97M33.82M22.86M22.33M20.05M15.50M2.93M1.22M73.71K
Research & Development27.80M20.84M28.64M26.44M24.96M17.25M9.65M5.99M2.58M44.57K
Other Operating ExpensesN/AN/AN/A665.00K666.00K-28.00K665.00K665.00K665.39KN/A
Operating Income-43.57M-58.06M-63.01M-49.97M-47.95M-37.96M-25.81M-9.59M-4.47M-308.57K
Other Expenses / Income1.36M-448.00K-646.00K114.00K983.00K418.00K247.00K68.00KN/A-396.00K
Before Tax Income-42.21M-58.51M-63.66M-49.85M-46.97M-37.55M-25.57M-9.52M-4.47M-514.29K
Income Tax ExpensesN/A448.00K-500.00K-114.00K-983.00K-28.00K-912.00K-94.00K-1.66M39.43K
Net Income-42.21M-58.95M-63.16M-49.74M-45.99M-37.55M-25.57M-9.52M-2.81M-474.86K
Interest Expenses1.36M448.00K646.00KN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding48.04M33.94M27.96M23.25M20.75M17.08M14.75M11.01M7.57M2.51M
Diluted Shares Outstanding48.04M33.94M27.96M23.25M20.75M17.08M14.75M11.01M7.57M2.51M
EBITDA-42.37M-56.70M-61.87M-48.87M-46.79M-36.65M-24.57M-8.83M-3.75M-108.00K
EBITDA Margin0.00%-8,100.29%-4,363.05%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-40.85M-58.06M-63.01M-49.85M-46.97M-37.57M-26.48M-9.61M-4.47M-435.43K
EBIT Margin0.00%-8,293.86%-4,443.86%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙